Cytokines in cancer therapy /

Saved in:
Bibliographic Details
Imprint:Basel ; New York : Karger, 1994.
Description:x, 392 p. : ill. ; 25 cm.
Language:English
Series:Beiträge zur Onkologie vol. 46
Subject:
Format: E-Resource Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/1618765
Hidden Bibliographic Details
Other authors / contributors:Bergmann, L. (Lothar)
Mitrou, Paris S.
ISBN:3805558090
Notes:Includes bibliographical references and index.

MARC

LEADER 00000cam a2200000 a 4500
001 1618765
003 ICU
005 19970814004800.0
008 940524s1994 sz a b 000 0 eng d
020 |a 3805558090 
035 |a (ICU)BID18682689 
035 |a (OCoLC)30564576 
040 |a CGU  |c CGU$dOrLoB 
245 0 0 |a Cytokines in cancer therapy /  |c volume editors, L. Bergmann, P.S. Mitrou. 
260 |a Basel ;  |a New York :  |b Karger,  |c 1994. 
300 |a x, 392 p. :  |b ill. ;  |c 25 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
440 0 |a Beiträge zur Onkologie  |v vol. 46 
504 |a Includes bibliographical references and index. 
505 0 0 |t The Cytokine Network /  |r F. R. Balkwill and M. S. Naylor --  |t Regulation of Major Histocompatibility Complex Class I Gene Expression in Oncogene-Transformed Mouse Fibroblasts /  |r B. Seliger, S. Lohmann, C. Huber and K. Pfizenmaier --  |t Combinations of Interferon-[alpha] with Other Cytokines as Initial and Second-Line Therapy of Chronic Myelogenous Leukemia /  |r O. Kloke --  |t The Role of Alpha-Interferon in Patients with Chronic Myeloid Leukemia Autografted in Chronic Phase /  |r P. De Fabritiis et al --  |t Interferon-[alpha] in the Treatment of CML: Comparison of Busulfan versus Hydroxyurea versus Interferon-[alpha] /  |r R. Hehlmann et al --  |t Clinical Significane of Interferons in the Treatment of Malignant Lymphomas /  |r M. Freund, H.-D. Kleine, P. Heussner and H. Poliwoda --  |t Interferon-[alpha] in the Treatment of B-Cell Chronic Lymphocytic Leukemia /  |r W. Knauf et al --  |t High-Dose Tumor Necrosis Factor-[alpha] in Combination with Interferon-[gamma] and Melphalan in Isolated Perfusion of the Limb for Irresectable Soft Tissue Sarcomas: A Highly Effective Approach to Achieve Limb Salvage /  |r A. M. M. Eggermont t al --  |t Potentiation of Growth Inhibition and Modulation of Differentiation in Human Malignant Glioblastomas by Combined Treatment with Recombinant Human Interferon-[alpha] and -[gamma] /  |r M. Doll, C. Huber and B. Seliger --  |t Immunotherapy and Chemotherapy in Anaplastic Thyroid Carcinoma - An Experimental Study /  |r H. J. C. Wenisch et al --  |t Endocrinologic Principles in the Therapeutic Use of Interleukin-2 /  |r K. A. Smith --  |t Activation and Therapy with Cytotoxic Lymphocytes: Current Dilemmas and New Directions /  |r E. Lotzova --  |t Tumor-Infiltrating Lymphocytes: Potential and Limitations to Their Use in Antineoplastic Therapy /  |r T. L. Whiteside --  |t The T-Cell Receptor [beta] Chain Variable Region Repertoire in Fresh and Cultured Lymphocytes Isolated from Human Malignant Melanomas /  |r E. Weidmann et al --  |t Interleukin-2 and Its Combination with Other Cytokines in Cancer Therapy /  |r L. Bergmann --  |t Early and Late Intravenous Interleukin-2 Infusion after Autologous Bone Marrow Transplantation: Report of Multicentric French Studies /  |r M. C. Favrot et al --  |t Immunotherapy in Marrow Transplantation - Interferon Early after Transplantation or IL-2-Activated Bone Marrow /  |r H.-G. Klingemann, H.-J. Gong, C. J. Eaves and G. L. Phillips --  |t The Local Availability of IL-2 Induces the Immune Recognition of an Otherwise 'Nonimmunogenic' Tumor /  |r F. Cavallo et al --  |t Subcutaneous rIL-2 in Advanced Melanoma and Kidney Carcinoma: Clinical and Biological Aspects /  |r M. Guida et al --  |t Treatment of Metastatic Melanoma with Interferon-[alpha] and High-Dose Interleukin-2 /  |r U. Keilholz et al --  |t Daily Alternating Administration of Interferon-[alpha]2b and Interleukin-2 Bolus Infusion in Two Different Dose Levels by Metastatic Renal Cell Cancer. Results of Two Phase II Studies /  |r L. Bergmann et al --  |t Treatment Strategies Employing Chemoimmunotherapy in Patients with Metastatic Renal Carcinoma /  |r J. Atzpodien, H. Kirchner and H. Poliwoda --  |t Inhalation of Natural Interleukin-2: Effectivity and Toxicity in Patients with Pulmonary Metastases of Renal Cell Carcinoma /  |r E. Huland, H. Heinzer, H. Schwaibold and H. Huland --  |t Antibody Formation to Interleukin-2 in Renal Cell Carcinoma Patients with Pulmonary Metastases Treated by Aerosol Therapy. Comparison of Western Blot and Enzyme-Linked Immunosorbent Assay Data /  |r U. Schwulera, E. Huland, W. G. Struff and R. Lissner --  |t No Antibody Formation in Cancer Patients Treated with Natural Interleukin-2 in Combination with Recombinant Interferon-[gamma] /  |r J. Knuver-Hopf et al --  |t Local Application of Lymphokine-Activated Killer Cells and Natural Interleukin-2 in Malignant Glioma Therapy /  |r F. Weber et al --  |t Real-Time Biospecific Interaction Analysis of Immobilized Interleukin-2 Receptor [beta]-Chain Peptides with Polyclonal Antibodies /  |r K. Schmitt et al --  |t The Total Cytokine Concept: The Influence of Soluble Receptors in the Cytokine Measurement /  |r D. Radoux and D. De Groote --  |t Development of Live Tumor Vaccines Using Retroviral Vectors for Transfer of Suicide Genes and Cytokines /  |r C. A. Mullen --  |t Generation of a Cellular Antitumor Immune Response by Retrovirally Mediated Cytokine Gene Transfer /  |r F. M. Rosenthal, K. Cronin, R. Guarini and B. Gansbacher --  |t Tumor-Cell-Targeted Interleukin-7 Gene Transfer Reveals T-Cell-Dependent Antitumor Activity in vivo /  |r H. Hock, M. Dorsch, T. Blankenstein and T. Diamantstein --  |t Detection of Cytokines Induced by and Involved in the Antitumor Response Provoked by Tumor Cell-Derived Interleukin-4 /  |r G. Richter, C. Platzer, T. Blankenstein and T. Diamantstein --  |t Phase I Dose Toxicity Clinical Evaluation of Interleukin-4 /  |r M. H. Gilleece et al --  |t Biological Properties of Human Interleukin-10 /  |r R. de Waal Malefyt and J. E. de Vries --  |t Transforming Growth Factor [beta] - Multiple Actions in Immune Function and Oncology /  |r J. Kekow and W. L. Gross --  |t Involvement of Cytokines in Graft-versus-Host Disease and Graft-versus-Leukemia Activity /  |r E. Holler et al --  |t Cytokine-Induced Adhesion Molecules and Tumor Spread /  |r A. Garofalo, R. Dossi and R. Giavazzi --  |t Up-Regulation of Adhesion Molecules by Immunotherapy as a Mechanism of Cytotoxicity in Renal Cell Cancer, Malignant Melanoma, and Acute Myelocytic Leukemia /  |r K. Fenchel, L. Bergmann, B. Jahn and P. S. Mitrou --  |t Immunological Detection and Surveillance of Residual Acute Myeloid Leukemia during Remission /  |r H. H. Gerhartz, H. Schmetzer and F. Mayer --  |t Regulation of H[subscript 4]biopterin Synthesis in Human Mononuclear Cells during Immune Response /  |r I. Ziegler, K. Schott and U. Schwulera --  |t Cytokines Directly Affect Contractility and Stress Protein Formation of Cardiac Myocytes /  |r I. Low-Friedrich et al --  |t Current Concepts and Future Prospects for Immunotherapeutic Approaches in Cancer Treatment /  |r T. L. Whiteside and R. B. Herberman. 
650 0 |a Cytokines  |x Therapeutic use  |x Testing. 
650 0 |a Cancer  |x Chemotherapy  |0 http://id.loc.gov/authorities/subjects/sh85019497 
650 7 |a Cancer  |x Chemotherapy.  |2 fast  |0 http://id.worldcat.org/fast/fst00845327 
650 7 |a Cytokines  |x Therapeutic use  |x Testing.  |2 fast  |0 http://id.worldcat.org/fast/fst00886276 
655 7 |a Conference papers and proceedings.  |2 fast  |0 http://id.worldcat.org/fast/fst01423772 
700 1 0 |a Bergmann, L.  |q (Lothar)  |0 http://id.loc.gov/authorities/names/no94018998  |1 http://viaf.org/viaf/122036710 
700 1 0 |a Mitrou, Paris S.  |0 http://id.loc.gov/authorities/names/n86002712  |1 http://viaf.org/viaf/69015527 
850 |a ICU 
901 |a ToCBNA 
903 |a HeVa 
929 |a cat 
999 f f |i d525dc9c-1a77-5549-a0fe-66a598d0a7d4  |s 68d717a8-00f2-5312-93ed-e359f984e8d2 
928 |t Library of Congress classification  |a RC271.C95C987 1994  |l ASR  |c ASR-SciASR  |i 5907839 
927 |t Library of Congress classification  |a RC271.C95C987 1994  |l ASR  |c ASR-SciASR  |e CRERAR  |b 39765614  |i 3065315